Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-17

Clinical Trial Update: Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sequential CD19 and CD22 CAR-T therapy for newly diagnosed Philadelphia chromosome–positive B-cell acute lymphoblastic leukemia has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CD19/CD22 CAR-T therapy

Snippet

Sponsor: Zhejiang University | Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult | Phase 2 | Status: COMPLETED